Pharmacokinetics of Cisplatin and Its Monohydrated Complex in Humans
- 1 August 1996
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 85 (8), 824-827
- https://doi.org/10.1021/js960037a
Abstract
The pharmacokinetics of cisplatin and its cytotoxic hydrolysis product cis-diammineaquachloroplatinum(II) ion (monohydrated complex) were investigated in seven patients after they received a 1-h infusion of cisplatin in normal saline at 100 mg/m2. The concentrations of intact cisplatin and the monohydrated complex were determined in blood by liquid chromatography with post-column derivatization, using diethyldithiocarbamate as the reagent. A pharmacokinetic model was developed assuming that a fraction of the dose (2.3%) is present as the monohydrated complex in the infusion solution and that reversible reactions between cisplatin and its monohydrated complex prevail. The clearances of cisplatin and the monohydrated complex were 0.32 +/- 0.05 and 0.27 +/- 0.11 L/min/m2, respectively. The apparent volume of distribution was considerably smaller for the monohydrated complex (4 +/- 2 L/m2) than for cisplatin (11 +/- 2 L/m2). The elimination rate constants were 0.030 +/- 0.002 and 0.07 +/- 0.02 min-1 for cisplatin and the monohydrated complex, respectively. The area under the time-concentration curve for the monohydrated complex was approximately 15% of that for cisplatin. It is concluded that the significant amounts of the monohydrated complex present in blood are due to the fraction already present in the administered dose and to the fraction formed in blood.This publication has 24 references indexed in Scilit:
- Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological mediaJournal of Pharmaceutical and Biomedical Analysis, 1990
- Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNAJournal of the American Chemical Society, 1990
- Effect of Sodium Thiosulfate on the Pharmacokinetics and Toxicity of CisplatinJNCI Journal of the National Cancer Institute, 1989
- Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancerCancer Chemotherapy and Pharmacology, 1989
- Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophilesBiochemical Pharmacology, 1987
- Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatinClinical Pharmacology & Therapeutics, 1986
- Intact cisplatin in urine following intravenous infusionJournal of Pharmacy and Pharmacology, 1982
- Pharmacokinetics of intact cisplatin in plasma. Infusion versus bolus dosingInternational Journal of Pharmaceutics, 1982
- Pharmacokinetic Studies with the Cancer Chemotherapeutic Agent CisplatinJournal of Pharmacy and Pharmacology, 1981
- Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNAChemico-Biological Interactions, 1980